MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, K.
Right arrow Articles by De Clercq, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, K.
Right arrow Articles by De Clercq, E.

Differential inhibitory effects of several pyrimidine 2',3'- dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases

K Ono, H Nakane, P Herdewijn, J Balzarini and E De Clercq

Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.

Several analogues of 2',3'-dideoxythymidine 5'-triphosphate [i.e., 3'- azido-2', 3'-dideoxythymidine 5'-triphosphate(Azdd TTP), 2',3'- didehydro-2',3'-dideoxythymidine 5'-triphosphate (ddeTTP), alpha, beta- methylene 3'-azido-2',3'-dideoxythymidine 5'-diphosphate, alpha, beta- methylene 3'-azido-2',3'-dideoxythymidine 5'-triphosphate, and beta, gamma-methylene 3'-azido-2',3'-dideoxythymidine 5'-triphosphate] and 2',3'-didehydro-2',3'-dideoxycytidine 5'-triphosphate (ddeCTP) have been evaluated for their inhibitory effects on murine retroviral reverse transcriptase and various other DNA polymerases, including DNA polymerases alpha, beta, and gamma, terminal deoxynucleotidyl transferase, and DNA polymerase I. None of the compounds inhibited the activity of DNA polymerase alpha under the reaction conditions employed. When Mg2+ was replaced by Mn2+, however, DNA polymerase alpha was strongly inhibited only by ddeTTP. DNA polymerase beta activity was inhibited only by ddeTTP and ddeCTP. All the compounds, except for ddeCTP, inhibited DNA polymerase gamma activity, ddeTTP being a particularly strong inhibitor of gamma-polymerase (Ki = 3.5 nM). Terminal deoxynucleotidyl transferase was only slightly inhibited by any of the compounds. AzddTTP was a potent inhibitor of reverse transcriptase (Ki = 42 nM), but it also inhibited the activities of DNA polymerase gamma and DNA polymerase I.

Volume 35, Issue 5, pp. 578-583, 05/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
L D Lewis, S Amin, C I Civin, and P S Lietman
Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production
Human and Experimental Toxicology, April 1, 2004; 23(4): 173 - 185.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
B. Schneider, R. Biondi, R. Sarfati, F. Agou, C. Guerreiro, D. Deville-Bonne, and M. Veron
The Mechanism of Phosphorylation of Anti-HIV D4T by Nucleoside Diphosphate Kinase
Mol. Pharmacol., May 1, 2000; 57(5): 948 - 953.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Kukhanova, X. Li, S.-H. Chen, I. King, T. Doyle, W. Prusoff, and Y.-C. Cheng
Interaction of beta -L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with Human Immunodeficiency Virus-1 Reverse Transcriptase and Human DNA Polymerases: Implications for Human Immunodeficiency Virus Drug Design
Mol. Pharmacol., May 1, 1998; 53(5): 801 - 807.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics